NASA agreed to rebook the Escapade satellites on NG-2 after managers with the principal investigator-led science mission devised a so-called “launch and loiter” strategy that would free Blue Origin ...

Ruvidar and Rutherrin show strong potential in treating bladder cancer, solid tumors, and HSV-1—including drug-resistant ...